Concourse Financial Group Securities’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1756 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3557 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3553 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3599 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3612 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3550 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3531 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3506 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3449 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3399 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3186 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3252 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3206 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3362 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3325 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3233 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3176 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3121 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2969 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2876 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2926 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2873 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2576 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2945 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2918 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2793 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2357 |
|